sur Champions Oncology, Inc. (NASDAQ:CSBR)
Champions Oncology Expands Bioanalytical Services with New Technology
Champions Oncology, Inc., a prominent oncology research organization, has announced enhancements to its bioanalytical services. The company has integrated Cytek Aurora flow cytometers into its offerings, boosting its capabilities in spectral and conventional flow cytometry. This development aims to deepen service complexity and competitiveness in the market.
The company also appointed Troy Tremaine to lead its bioanalytical commercial strategy. With extensive experience in the field, Tremaine is expected to drive growth in this business area. CEO Ronnie Morris expressed enthusiasm about these strategic investments and the potential benefits they bring to the company's growth trajectory.
R. P.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Champions Oncology, Inc.